Articles from JCN Newswires (April 26, 2006)

Title	Author	Type	Words
Chugai Announces Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, on Rheumatoid Arthritis Patients.			698
Honda Announces Consolidated Financial Summary for the Fiscal Year Ended March 31, 2006 and Forecast for the Fiscal Year Ending March 31, 2007.			1383
Honda's Stock Split and the Change of Ratio of ADR to Underlying Shares.			644
Metropolis Magazine Launches Japan Podcast.			631
NEC Announces Executive Personnel Changes.			357
NEC Fielding Announces Consolidated Financial Results for the Full Year Ended March 31, 2006.			2134
Sanix Announces Stock Option Plan.			481